The current price of UMA (UMA) is $1.69, as of February 17, 2025. Over the last 24 hours, the price has moved by -0.99%, with a change of 0.69% in the past hour. For longer-term performance, the price ...

All PWD zones have been directed to start road repair work and report roads needing major strengthening and re-carpeting ...

Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European ...

The FDA has approved BridgeBio Pharma's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market showdown with its larger rival Pfizer.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of BridgeBio Pharma stock opened at $31.95 on Thursday. The firm has a market capitalization of $6.04 billion, a PE ratio of -13.26 and a beta of 1.07. The company’s fifty day moving ...

After hours: February 14 at 7:57:57 PM EST ...

The European Commission has approved BridgeBio's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market clash with Pfizer.

BridgeBio Pharma has a twelve month low of $21.62 and a twelve month high of $41.04. Insider Activity In other news, CEO Neil Kumar sold 27,389 shares of the business’s stock in a transaction ...